1. Home
  2. AMPH vs IART Comparison

AMPH vs IART Comparison

Compare AMPH & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$19.31

Market Cap

971.8M

Sector

Health Care

ML Signal

HOLD

Logo Integra LifeSciences Holdings Corporation

IART

Integra LifeSciences Holdings Corporation

HOLD

Current Price

$13.91

Market Cap

823.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMPH
IART
Founded
1996
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
971.8M
823.8M
IPO Year
2005
1996

Fundamental Metrics

Financial Performance
Metric
AMPH
IART
Price
$19.31
$13.91
Analyst Decision
Buy
Hold
Analyst Count
8
7
Target Price
$28.38
$14.33
AVG Volume (30 Days)
371.8K
954.1K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.14
N/A
Revenue
$719,887,000.00
N/A
Revenue This Year
$6.90
$4.39
Revenue Next Year
$4.64
$3.40
P/E Ratio
$11.87
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.03
$8.70
52 Week High
$31.26
$16.42

Technical Indicators

Market Signals
Indicator
AMPH
IART
Relative Strength Index (RSI) 36.58 72.93
Support Level $18.92 $12.90
Resistance Level $20.08 $14.38
Average True Range (ATR) 0.80 0.71
MACD -0.03 0.37
Stochastic Oscillator 14.80 89.60

Price Performance

Historical Comparison
AMPH
IART

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

About IART Integra LifeSciences Holdings Corporation

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.

Share on Social Networks: